DAL
62
-4
LEG
27
-2
BAX
30
-3
MPC
52
8
PLD
51
-5
HAS
55
-2
IR
72
-5
MAR
60
7
PSA
66
3
T
56
2
CMS
67
3
PCG
80
3
NVDA
52
-3
GME
63
12
BAC
41
-6
MAT
51
-3
ESS
60
-8
ADM
33
-3
KLAC
61
-2
MCD
67
2
DAL
62
-4
LEG
27
-2
BAX
30
-3
MPC
52
8
PLD
51
-5
HAS
55
-2
IR
72
-5
MAR
60
7
PSA
66
3
T
56
2
CMS
67
3
PCG
80
3
NVDA
52
-3
GME
63
12
BAC
41
-6
MAT
51
-3
ESS
60
-8
ADM
33
-3
KLAC
61
-2
MCD
67
2
Financhill
Back

Iterum Therapeutics PLC Quote, Financials, Valuation and Earnings

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

ITRM
Iterum Therapeutics PLC

Last Price:
1.06
Seasonality Move:
3.58%

7 Day Trial

ALL ACCESS PASS

$ 7

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Iterum Therapeutics PLC Price Quote

$1.06
+0.01 (+-2.75%)
(Updated: September 21, 2024 at 6:29 AM ET)

Iterum Therapeutics PLC Key Stats

Sell
37
Iterum Therapeutics PLC (ITRM) is a Sell
Day range:
$0.99 - $1.10
52-week range:
$0.62 - $2.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
20.14
P/B ratio:
0%
Volume:
229.8K
Avg. volume:
361K
1-year change:
45.32%
Market cap:
$17.5M
Revenue:
$0
EPS:
$-2.65

How Much Does Iterum Therapeutics PLC Make?

Data Unavailable

Is Iterum Therapeutics PLC Growing As A Company?

Data Unavailable

Iterum Therapeutics PLC Stock Price Performance

What Is Iterum Therapeutics PLC 52-Week High & Low?

Iterum Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Iterum Therapeutics PLC?

Is Iterum Therapeutics PLC Cash Flow Positive?

  • What Is ITRM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$42.8M
  • What Is Iterum Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $8M
  • What Is Iterum Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $25.4M

Iterum Therapeutics PLC Return On Invested Capital

Data Unavailable

Iterum Therapeutics PLC Earnings Date & Stock Price

Iterum Therapeutics PLC Competitors

Iterum Therapeutics PLC Dividend Yield

Iterum Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 29.63%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 468.72%

Major Shareholders

  • How many ITRM shares are owned by institutional investors?
    444K ITRM shares are owned by institutional investors
  • How many ITRM shares are owned by insiders?
    511.1K ITRM shares are owned by insiders